HCW Biologics Inc.
HCWB
$7.77
$0.7210.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.12% | -89.19% | -105.09% | -52.90% | -67.74% |
| Total Depreciation and Amortization | 4.33% | -30.79% | -8.24% | 23.57% | 58.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.16% | 793.41% | 613.18% | 502.57% | 357.55% |
| Change in Net Operating Assets | 392.98% | 434.59% | 678.99% | -162.62% | -286.60% |
| Cash from Operations | 36.81% | 31.78% | 6.19% | -80.82% | -116.77% |
| Capital Expenditure | 95.78% | -51.19% | 63.15% | 42.84% | 39.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -41.12% | -41.12% | -59.97% |
| Cash from Investing | -106.89% | -151.90% | 13.40% | -38.30% | -74.18% |
| Total Debt Issued | -- | -- | -42.62% | -72.86% | -- |
| Total Debt Repaid | -211.75% | -1,207.78% | -- | -- | -- |
| Issuance of Common Stock | 39,651.05% | 16,134.19% | 14,615.79% | 16,290.26% | 50.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106,733.56% | 22,935.29% | -2.48% | -32.95% | -100.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.76% | 31.86% | 21.12% | -5,347.80% | -276.78% |